Hugel

Hugel has established itself as a global leader in medical aesthetics since its founding in South Korea in 2001. Its flagship product line includes botulinum toxin injectables—marketed under various names such as Botulax domestically and Letybo internationally—which have received regulatory approval across the US, China, Europe, Australia, Canada, and more. The company also markets hyaluronic acid fillers ("The Chaeum", "Dermalax"), absorbable sutures ("BlueRose"), threads for lifting procedures, skin boosters/cosmetics ("Wellage"), and related devices. Clinical results from phase III studies support efficacy/safety of letibotulinumtoxinA for glabellar lines; the company aims to capture significant market share globally.[2][4][5]